S. M. Seidlin, L. D. Marinelli, and E. Oshry, Radioactive iodine therapy: effect on functioning metastases of adenocarcinoma of the thyroid, CA Cancer J Clin, vol.40, issue.5, pp.299-317, 1990.

M. Martín, R. C. Geysels, V. Peyret, B. Barquero, C. E. Masini-repiso et al., Implications of Na+/I-Symporter Transport to the Plasma Membrane for Thyroid Hormonogenesis and Radioiodide Therapy, J Endocr Soc, vol.3, issue.1, pp.222-256, 2019.

R. Solans, J. Bosch, P. Galofre, F. Porta, J. Rosello et al., Salivary and Lacrimal Gland Dysfunction (Sicca Syndrome) After Radioiodine Therapy, p.7

L. Lu, F. Shan, W. Li, and H. Lu, Short-Term Side Effects after Radioiodine Treatment in Patients with Differentiated Thyroid Cancer, BioMed Research International, vol.2016, pp.1-5, 2016.

S. L. Lee, Complications of Radioactive Iodine Treatment of Thyroid Carcinoma, vol.8, pp.1277-87, 2010.

S. M. Lee, J. W. Lee, S. Y. Kim, S. W. Han, and W. K. Bae, Prediction of risk for symptomatic sialadenitis by post-therapeutic dual 131I scintigraphy in patients with differentiated thyroid cancer, Annals of Nuclear Medicine, vol.27, issue.8, pp.700-709, 2013.

S. Hyer, A. Kong, B. Pratt, and C. Harmer, Salivary Gland Toxicity after Radioiodine Therapy for Thyroid Cancer, Clinical Oncology, vol.19, issue.1, pp.83-89, 2007.

A. Fard-esfahani, A. Emami-ardekani, B. Fallahi, P. Fard-esfahani, D. Beiki et al., Adverse effects of radioactive iodine-131 treatment for differentiated thyroid carcinoma: Nuclear Medicine Communications, 2001.

F. L. Da-fonseca, P. K. Yamanaka, L. Mazoti, L. Arakawa-sugueno, J. M. Kato et al., Correlation among ocular surface disease, xerostomia, and nasal symptoms in patients with differentiated thyroid carcinoma subjected to radioiodine therapy: A prospective comparative study, Head & Neck, vol.39, issue.12, pp.2381-96, 2017.

F. I. Daniel, L. D. Lima, L. J. Grando, R. Castro, E. Cordeiro et al., Salivary evaluation in radioactive I 131 treated patients with thyroid carcinoma, Acta Odontologica Scandinavica, vol.76, issue.2, pp.148-52, 2018.

G. Sunavala-dossabhoy, Radioactive iodine: An unappreciated threat to salivary gland function, Oral Diseases, vol.24, issue.1-2, pp.198-201, 2018.

A. E. Geres, P. Szafryk-mereshian, S. Fernández, R. Caro, D. G. Castro et al., Sialoadenitis por radioyodo. Análisis de factores que influyen en la respuesta al tratamiento médico. Endocrinología y Nutrición, vol.62, pp.493-501, 2015.

S. B. Jensen, A. Vissink, E. Andersen, C. G. Brown, A. N. Davies et al., A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life. Supportive Care in Cancer, vol.18, pp.1039-60, 2010.

C. Rubino, F. De-vathaire, M. E. Dottorini, P. Hall, C. Schvartz et al., Second primary malignancies in thyroid cancer patients, British Journal of Cancer, vol.89, issue.9, pp.1638-1682, 2003.
URL : https://hal.archives-ouvertes.fr/inserm-00122276

S. C. Clement, R. P. Peeters, C. M. Ronckers, T. P. Links, M. M. Van-den-heuvel-eibrink et al., Intermediate and long-term adverse effects of radioiodine therapy for differentiated thyroid carcinoma -A systematic review, Cancer Treatment Reviews, vol.41, issue.10, pp.925-959, 2015.

Z. Noaparast and S. J. Hosseinimehr, Radioprotective agents for the prevention of side effects induced by radioiodine-131 therapy, Future Oncology, vol.9, issue.8, pp.1145-59, 2013.

E. Moreddu, K. Baumstarck-barrau, S. Gabriel, N. Fakhry, F. Sebag et al., Incidence of salivary side effects after radioiodine treatment using a new specificallydesigned questionnaire. British Journal of Oral and Maxillofacial Surgery, vol.55, pp.609-621, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01788386

J. P. Almeida, Á. E. Sanabria, E. Lima, and L. P. Kowalski, Late side effects of radioactive iodine on salivary gland function in patients with thyroid cancer. Head Neck, vol.33, pp.686-90, 2011.

B. Bader, Intermediate and Long-Term Side Effects of High-. Dose Radioiodine Therapy for Thyroid Carcinoma, p.5

Y. An, J. Yoon, S. J. Lee, H. Song, S. Yoon et al., Symptomatic late-onset sialadenitis after radioiodine therapy in thyroid cancer, Ann Nucl Med, vol.27, issue.4, pp.386-91, 2013.

I. F. Dingle, A. E. Mishoe, S. A. Nguyen, L. J. Overton, and M. B. Gillespie, Salivary Morbidity and Quality of Life following Radioactive Iodine for Well-Differentiated Thyroid Cancer. Otolaryngol Head Neck Surg, vol.148, pp.746-52, 2013.

B. L. Malpani, R. S. Quantification, . Salivary, and . Function, THYROID CANCER PATIENTS TREATED WITH RADIOIODINE, p.6

B. L. Prendes, L. A. Orloff, and D. W. Eisele, Therapeutic sialendoscopy for the management of radioiodine sialadenitis. Arch Otolaryngol Head Neck Surg, vol.138, pp.15-24, 2012.

P. Florenzano, F. J. Guarda, R. Jaimovich, N. Droppelmann, H. González et al., Radioactive Iodine Administration Is Associated with Persistent Related Symptoms in Patients with Differentiated Thyroid Cancer, International Journal of Endocrinology, vol.2016, pp.1-6, 2016.

S. Anil, S. Vellappally, M. Hashem, R. S. Preethanath, S. Patil et al., Xerostomia in geriatric patients: a burgeoning global concern, J Investig Clin Dent, vol.7, issue.1, pp.5-12, 2016.

A. Johansson, A. Johansson, L. Unell, G. Ekbäck, S. Ordell et al., Self-reported dry mouth in 50-to 80-year-old Swedes: Longitudinal and cross-sectional population studies, J Oral Rehabil, 2019.

A. Gentric,

, Rev Prat, vol.51, issue.2, pp.177-80, 2001.

A. Johansson, A. Johansson, L. Unell, G. Ekbäck, S. Ordell et al., A 15-yr longitudinal study of xerostomia in a Swedish population of 50-yr-old subjects. European journal of oral sciences, vol.117, pp.13-22, 2009.

A. Johansson, A. Johansson, L. Unell, G. Ekbäck, S. Ordell et al., Self-reported dry mouth in Swedish population samples aged 50, 65 and 75 years, Gerodontology, vol.29, issue.2, pp.107-122, 2012.

L. R. Azevedo, J. H. Damante, V. S. Lara, and J. Lauris, Age-related changes in human sublingual glands: a post mortem study, Arch Oral Biol, vol.50, issue.6, pp.565-74, 2005.

J. P. Waterhouse, D. M. Chisholm, R. B. Winter, M. Patel, and R. S. Yale, Replacement of functional parenchymal cells by fat and connective tissue in human submandibular salivary glands: an age-related change, J Oral Pathol, vol.2, issue.1, pp.16-27, 1973.

S. Y. Jeong, H. W. Kim, S. Lee, B. Ahn, and J. Lee, Salivary Gland Function 5 Years After Radioactive Iodine Ablation in Patients with Differentiated Thyroid Cancer: Direct Comparison of Pre-and Postablation Scintigraphies and Their Relation to Xerostomia Symptoms, Thyroid, vol.23, issue.5, pp.609-625, 2013.

L. Morris, R. M. Tuttle, and L. Davies, Changing Trends in the Incidence of Thyroid Cancer in the United States, JAMA Otolaryngol Head Neck Surg, vol.142, issue.7, pp.709-720, 201601.

D. Albano, F. Bertagna, M. B. Panarotto, and R. Giubbini, Early and late adverse effects of radioiodine for pediatric differentiated thyroid cancer. Pediatr Blood Cancer, vol.64, p.26595, 2017.

T. Selvakumar, M. Nies, K. Hesselink, M. S. Brouwers, A. H. Van-der-horst-schrivers et al., Long-Term Effects of Radioiodine Treatment on Salivary Gland Function in Adult Survivors of Pediatric Differentiated Thyroid Carcinoma, J Nucl Med, vol.60, issue.2, pp.172-179, 2019.

M. Trufero, J. Capdevilla, J. Cruz, J. J. Isla, and D. , SEOM clinical guidelines for the treatment of thyroid cancer, Clin Transl Oncol, vol.13, issue.8, pp.574-583, 2011.

J. Chung and G. J. Cheon, Radioiodine therapy in differentiated thyroid cancer: the first targeted therapy in oncology, Endocrinol Metab (Seoul), vol.29, issue.3, pp.233-242, 2014.

H. H. Albrecht and H. Creutzig, Salivary gland scintigraphy after radio-iodine therapy. Functional scintigraphy of the salivary gland after high dose radio-iodine therapy

, Rofo, vol.125, issue.6, pp.546-51, 1976.

Y. K. Maheshwari, C. S. Hill, T. P. Haynie, R. C. Hickey, and N. A. Samaan, 131I therapy in differentiated thyroid carcinoma: M. D. Anderson Hospital experience. Cancer, vol.47, pp.664-71, 1981.

J. Jonklaas, Nasal symptoms after radioiodine therapy: a rarely described side effect with similar frequency to lacrimal dysfunction, Thyroid, vol.24, issue.12, pp.1806-1820, 2014.

A. Konings, R. P. Coppes, and A. Vissink, On the mechanism of salivary gland radiosensitivity, Int J Radiat Oncol Biol Phys, vol.62, issue.4, pp.1187-94, 2005.

K. Nakada, T. Ishibashi, T. Takei, K. Hirata, K. Shinohara et al., Does Lemon Candy Decrease Salivary Gland Damage After Radioiodine Therapy for Thyroid Cancer, p.7

K. Kulkarni, D. Van-nostrand, F. Atkins, M. Mete, J. Wexler et al., Does lemon juice increase radioiodine reaccumulation within the parotid glands more than if lemon juice is not administered?: Nuclear Medicine Communications, vol.35, pp.210-216, 2014.

W. Jentzen, M. Richter, J. Nagarajah, T. D. Poeppel, W. Brandau et al., Chewinggum stimulation did not reduce the absorbed dose to salivary glands during radioiodine treatment of thyroid cancer as inferred from pre-therapy 124I PET/CT imaging, EJNMMI Phys, vol.1, issue.1, p.100, 2014.

J. M. Kim, J. W. Kim, M. E. Choi, S. Kim, Y. Kim et al., Protective effects of curcumin on radioiodine-induced salivary gland dysfunction in mice, J Tissue Eng Regen Med, vol.13, issue.4, pp.674-81, 2019.

M. Haghighatafshar, M. Ghaedian, Z. Etemadi, S. M. Entezarmahdi, and T. Ghaedian, Pilocarpine effect on dose rate of salivary gland in differentiated thyroid carcinoma patients treated with radioiodine: Nuclear Medicine Communications, vol.39, pp.430-434, 2018.

A. Upadhyaya, P. Zhou, Z. Meng, P. Wang, G. Zhang et al., Radioprotective effect of vitamin E on salivary glands after radioiodine therapy for differentiated thyroid cancer: a randomized-controlled trial, Nuclear Medicine Communications, vol.38, issue.11, pp.891-903, 2017.

Y. H. Zeidan, N. Xiao, H. Cao, C. Kong, Q. Le et al., Botulinum Toxin Confers Radioprotection in Murine Salivary Glands, International Journal of Radiation Oncology*Biology*Physics, vol.94, issue.5, pp.1190-1197, 2016.

C. L. Breen, A. P. Shakeshaft, C. M. Doran, R. W. Sanson-fisher, and R. P. Mattick, Costeffectiveness of follow-up contact for a postal survey: a randomised controlled trial, Aust N Z J Public Health, vol.34, issue.5, pp.508-520, 2010.

J. Jonklaas, H. Wang, and G. Esposito, Salivary Function after Radioiodine Therapy: Poor Correlation between Symptoms and Salivary Scintigraphy, Front Endocrinol (Lausanne), vol.6, p.100, 2015.

J. Wu, H. Feng, W. Ouyang, Y. Sun, P. Chen et al., Systematic evaluation of salivary gland damage following I-131 therapy in differentiated thyroid cancer patients by quantitative scintigraphy and clinical follow-up: Nuclear Medicine Communications, vol.36, pp.819-845, 2015.

M. Caglar, M. Tuncel, and R. Alpar, Scintigraphic Evaluation of Salivary Gland Dysfunction in Patients with Thyroid Cancer After Radioiodine Treatment: Clinical Nuclear Medicine, vol.27, pp.767-71, 2002.

S. R. Baker, C. L. Pankhurst, and P. G. Robinson, Utility of two oral health-related quality-of-life measures in patients with xerostomia. Community dentistry and oral epidemiology, vol.34, pp.351-62, 2006.

B. Strömbeck, C. Ekdahl, R. Manthorpe, I. Wikström, and L. Jacobsson, Health-related quality of life in primary Sjögren's syndrome, rheumatoid arthritis and fibromyalgia compared to normal population data using SF-36, Scandinavian journal of rheumatology, vol.29, issue.1, pp.20-28, 2000.

K. D. Hay, R. P. Morton, and C. R. Wall, Quality of life and nutritional studies in Sjogren's syndrome patients with xerostomia. The New Zealand dental journal, vol.97, pp.128-159, 2001.

J. Rostron, S. Rogers, L. Longman, S. Kancy, and E. A. Field, Health-related quality of life in patients with Primary Sjögren's Syndrome and Xerostomia: a comparative study, Gerodontology, vol.19, issue.1, pp.53-62, 2002.

M. Roux, Cyrille Chossegros, vol.3, issue.1, p.3

C. Aphm and . Conception, Department of Maxillofacial surgery and stomatology of Pr Chossegros, 147 Boulevard Baille, 13005.

, SPMC EA, vol.3279, p.13284

M. Cedex-07, F. Pr, Y. Seidlin, S. M. Marinelli, L. D. Oshry et al., Radioactive iodine therapy: effect on functioning metastases of adenocarcinoma of the thyroid, CA Cancer J Clin, vol.40, issue.5, pp.299-317, 1990.

M. Martín, R. C. Geysels, V. Peyret, B. Barquero, C. E. Masini-repiso et al., Implications of Na+/I-Symporter Transport to the Plasma Membrane for Thyroid Hormonogenesis and Radioiodide Therapy, J Endocr Soc, vol.3, issue.1, pp.222-256, 2019.

R. Solans, J. Bosch, P. Galofre, F. Porta, J. Rosello et al., Salivary and Lacrimal Gland Dysfunction (Sicca Syndrome) After Radioiodine Therapy, p.7

L. Lu, F. Shan, W. Li, and H. Lu, Short-Term Side Effects after Radioiodine Treatment in Patients with Differentiated Thyroid Cancer, BioMed Research International, vol.2016, pp.1-5, 2016.

S. L. Lee, Complications of Radioactive Iodine Treatment of Thyroid Carcinoma, vol.8, pp.1277-87, 2010.

S. M. Lee, J. W. Lee, S. Y. Kim, S. W. Han, and W. K. Bae, Prediction of risk for symptomatic sialadenitis by post-therapeutic dual 131I scintigraphy in patients with differentiated thyroid cancer, Annals of Nuclear Medicine, vol.27, issue.8, pp.700-709, 2013.

S. Hyer, A. Kong, B. Pratt, and C. Harmer, Salivary Gland Toxicity after Radioiodine Therapy for Thyroid Cancer, Clinical Oncology, vol.19, issue.1, pp.83-89, 2007.

A. Fard-esfahani, A. Emami-ardekani, B. Fallahi, P. Fard-esfahani, D. Beiki et al., Adverse effects of radioactive iodine-131 treatment for differentiated thyroid carcinoma: Nuclear Medicine Communications, 2001.

F. L. Da-fonseca, P. K. Yamanaka, L. Mazoti, L. Arakawa-sugueno, J. M. Kato et al., Correlation among ocular surface disease, xerostomia, and nasal symptoms in patients with differentiated thyroid carcinoma subjected to radioiodine therapy: A prospective comparative study, Head & Neck, vol.39, issue.12, pp.2381-96, 2017.

F. I. Daniel, L. D. Lima, L. J. Grando, R. Castro, E. Cordeiro et al., Salivary evaluation in radioactive I 131 treated patients with thyroid carcinoma, Acta Odontologica Scandinavica, vol.76, issue.2, pp.148-52, 2018.

G. Sunavala-dossabhoy, Radioactive iodine: An unappreciated threat to salivary gland function, Oral Diseases, vol.24, issue.1-2, pp.198-201, 2018.

A. E. Geres, P. Szafryk-mereshian, S. Fernández, R. Caro, D. G. Castro et al., Sialoadenitis por radioyodo. Análisis de factores que influyen en la respuesta al tratamiento médico. Endocrinología y Nutrición, vol.62, pp.493-501, 2015.

S. B. Jensen, A. Vissink, E. Andersen, C. G. Brown, A. N. Davies et al., A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life. Supportive Care in Cancer, vol.18, pp.1039-60, 2010.

C. Rubino, F. De-vathaire, M. E. Dottorini, P. Hall, C. Schvartz et al., Second primary malignancies in thyroid cancer patients, British Journal of Cancer, vol.89, issue.9, pp.1638-1682, 2003.
URL : https://hal.archives-ouvertes.fr/inserm-00122276

S. C. Clement, R. P. Peeters, C. M. Ronckers, T. P. Links, M. M. Van-den-heuvel-eibrink et al., Intermediate and long-term adverse effects of radioiodine therapy for differentiated thyroid carcinoma -A systematic review, Cancer Treatment Reviews, vol.41, issue.10, pp.925-959, 2015.

Z. Noaparast and S. J. Hosseinimehr, Radioprotective agents for the prevention of side effects induced by radioiodine-131 therapy, Future Oncology, vol.9, issue.8, pp.1145-59, 2013.

E. Moreddu, K. Baumstarck-barrau, S. Gabriel, N. Fakhry, F. Sebag et al., Incidence of salivary side effects after radioiodine treatment using a new specificallydesigned questionnaire. British Journal of Oral and Maxillofacial Surgery, vol.55, pp.609-621, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01788386

J. P. Almeida, Á. E. Sanabria, E. Lima, and L. P. Kowalski, Late side effects of radioactive iodine on salivary gland function in patients with thyroid cancer. Head Neck, vol.33, pp.686-90, 2011.

B. Bader, Intermediate and Long-Term Side Effects of High-. Dose Radioiodine Therapy for Thyroid Carcinoma, p.5

Y. An, J. Yoon, S. J. Lee, H. Song, S. Yoon et al., Symptomatic late-onset sialadenitis after radioiodine therapy in thyroid cancer, Ann Nucl Med, vol.27, issue.4, pp.386-91, 2013.

I. F. Dingle, A. E. Mishoe, S. A. Nguyen, L. J. Overton, and M. B. Gillespie, Salivary Morbidity and Quality of Life following Radioactive Iodine for Well-Differentiated Thyroid Cancer. Otolaryngol Head Neck Surg, vol.148, pp.746-52, 2013.

B. L. Malpani, R. S. Quantification, . Salivary, and . Function, THYROID CANCER PATIENTS TREATED WITH RADIOIODINE, p.6

B. L. Prendes, L. A. Orloff, and D. W. Eisele, Therapeutic sialendoscopy for the management of radioiodine sialadenitis. Arch Otolaryngol Head Neck Surg, vol.138, pp.15-24, 2012.

P. Florenzano, F. J. Guarda, R. Jaimovich, N. Droppelmann, H. González et al., Radioactive Iodine Administration Is Associated with Persistent Related Symptoms in Patients with Differentiated Thyroid Cancer, International Journal of Endocrinology, vol.2016, pp.1-6, 2016.

S. Anil, S. Vellappally, M. Hashem, R. S. Preethanath, S. Patil et al., Xerostomia in geriatric patients: a burgeoning global concern, J Investig Clin Dent, vol.7, issue.1, pp.5-12, 2016.

A. Johansson, A. Johansson, L. Unell, G. Ekbäck, S. Ordell et al., Self-reported dry mouth in 50-to 80-year-old Swedes: Longitudinal and cross-sectional population studies, J Oral Rehabil, 2019.

A. Gentric,

, Rev Prat, vol.51, issue.2, pp.177-80, 2001.

A. Johansson, A. Johansson, L. Unell, G. Ekbäck, S. Ordell et al., A 15-yr longitudinal study of xerostomia in a Swedish population of 50-yr-old subjects. European journal of oral sciences, vol.117, pp.13-22, 2009.

A. Johansson, A. Johansson, L. Unell, G. Ekbäck, S. Ordell et al., Self-reported dry mouth in Swedish population samples aged 50, 65 and 75 years, Gerodontology, vol.29, issue.2, pp.107-122, 2012.

L. R. Azevedo, J. H. Damante, V. S. Lara, and J. Lauris, Age-related changes in human sublingual glands: a post mortem study, Arch Oral Biol, vol.50, issue.6, pp.565-74, 2005.

J. P. Waterhouse, D. M. Chisholm, R. B. Winter, M. Patel, and R. S. Yale, Replacement of functional parenchymal cells by fat and connective tissue in human submandibular salivary glands: an age-related change, J Oral Pathol, vol.2, issue.1, pp.16-27, 1973.

S. Y. Jeong, H. W. Kim, S. Lee, B. Ahn, and J. Lee, Salivary Gland Function 5 Years After Radioactive Iodine Ablation in Patients with Differentiated Thyroid Cancer: Direct Comparison of Pre-and Postablation Scintigraphies and Their Relation to Xerostomia Symptoms, Thyroid, vol.23, issue.5, pp.609-625, 2013.

L. Morris, R. M. Tuttle, and L. Davies, Changing Trends in the Incidence of Thyroid Cancer in the United States, JAMA Otolaryngol Head Neck Surg, vol.142, issue.7, pp.709-720, 201601.

D. Albano, F. Bertagna, M. B. Panarotto, and R. Giubbini, Early and late adverse effects of radioiodine for pediatric differentiated thyroid cancer. Pediatr Blood Cancer, vol.64, p.26595, 2017.

T. Selvakumar, M. Nies, K. Hesselink, M. S. Brouwers, A. H. Van-der-horst-schrivers et al., Long-Term Effects of Radioiodine Treatment on Salivary Gland Function in Adult Survivors of Pediatric Differentiated Thyroid Carcinoma, J Nucl Med, vol.60, issue.2, pp.172-179, 2019.

M. Trufero, J. Capdevilla, J. Cruz, J. J. Isla, and D. , SEOM clinical guidelines for the treatment of thyroid cancer, Clin Transl Oncol, vol.13, issue.8, pp.574-583, 2011.

J. Chung and G. J. Cheon, Radioiodine therapy in differentiated thyroid cancer: the first targeted therapy in oncology, Endocrinol Metab (Seoul), vol.29, issue.3, pp.233-242, 2014.

H. H. Albrecht and H. Creutzig, Salivary gland scintigraphy after radio-iodine therapy. Functional scintigraphy of the salivary gland after high dose radio-iodine therapy

, Rofo, vol.125, issue.6, pp.546-51, 1976.

Y. K. Maheshwari, C. S. Hill, T. P. Haynie, R. C. Hickey, and N. A. Samaan, 131I therapy in differentiated thyroid carcinoma: M. D. Anderson Hospital experience. Cancer, vol.47, pp.664-71, 1981.

J. Jonklaas, Nasal symptoms after radioiodine therapy: a rarely described side effect with similar frequency to lacrimal dysfunction, Thyroid, vol.24, issue.12, pp.1806-1820, 2014.

A. Konings, R. P. Coppes, and A. Vissink, On the mechanism of salivary gland radiosensitivity, Int J Radiat Oncol Biol Phys, vol.62, issue.4, pp.1187-94, 2005.

K. Nakada, T. Ishibashi, T. Takei, K. Hirata, K. Shinohara et al., Does Lemon Candy Decrease Salivary Gland Damage After Radioiodine Therapy for Thyroid Cancer, p.7

K. Kulkarni, D. Van-nostrand, F. Atkins, M. Mete, J. Wexler et al., Does lemon juice increase radioiodine reaccumulation within the parotid glands more than if lemon juice is not administered?: Nuclear Medicine Communications, vol.35, pp.210-216, 2014.

W. Jentzen, M. Richter, J. Nagarajah, T. D. Poeppel, W. Brandau et al., Chewinggum stimulation did not reduce the absorbed dose to salivary glands during radioiodine treatment of thyroid cancer as inferred from pre-therapy 124I PET/CT imaging, EJNMMI Phys, vol.1, issue.1, p.100, 2014.

J. M. Kim, J. W. Kim, M. E. Choi, S. Kim, Y. Kim et al., Protective effects of curcumin on radioiodine-induced salivary gland dysfunction in mice, J Tissue Eng Regen Med, vol.13, issue.4, pp.674-81, 2019.

M. Haghighatafshar, M. Ghaedian, Z. Etemadi, S. M. Entezarmahdi, and T. Ghaedian, Pilocarpine effect on dose rate of salivary gland in differentiated thyroid carcinoma patients treated with radioiodine: Nuclear Medicine Communications, vol.39, pp.430-434, 2018.

A. Upadhyaya, P. Zhou, Z. Meng, P. Wang, G. Zhang et al., Radioprotective effect of vitamin E on salivary glands after radioiodine therapy for differentiated thyroid cancer: a randomized-controlled trial, Nuclear Medicine Communications, vol.38, issue.11, pp.891-903, 2017.

Y. H. Zeidan, N. Xiao, H. Cao, C. Kong, Q. Le et al., Botulinum Toxin Confers Radioprotection in Murine Salivary Glands, International Journal of Radiation Oncology*Biology*Physics, vol.94, issue.5, pp.1190-1197, 2016.

C. L. Breen, A. P. Shakeshaft, C. M. Doran, R. W. Sanson-fisher, and R. P. Mattick, Costeffectiveness of follow-up contact for a postal survey: a randomised controlled trial, Aust N Z J Public Health, vol.34, issue.5, pp.508-520, 2010.

J. Jonklaas, H. Wang, and G. Esposito, Salivary Function after Radioiodine Therapy: Poor Correlation between Symptoms and Salivary Scintigraphy, Front Endocrinol (Lausanne), vol.6, p.100, 2015.

J. Wu, H. Feng, W. Ouyang, Y. Sun, P. Chen et al., Systematic evaluation of salivary gland damage following I-131 therapy in differentiated thyroid cancer patients by quantitative scintigraphy and clinical follow-up: Nuclear Medicine Communications, vol.36, pp.819-845, 2015.

M. Caglar, M. Tuncel, and R. Alpar, Scintigraphic Evaluation of Salivary Gland Dysfunction in Patients with Thyroid Cancer After Radioiodine Treatment: Clinical Nuclear Medicine, vol.27, pp.767-71, 2002.

S. R. Baker, C. L. Pankhurst, and P. G. Robinson, Utility of two oral health-related quality-of-life measures in patients with xerostomia. Community dentistry and oral epidemiology, vol.34, pp.351-62, 2006.

B. Strömbeck, C. Ekdahl, R. Manthorpe, I. Wikström, and L. Jacobsson, Health-related quality of life in primary Sjögren's syndrome, rheumatoid arthritis and fibromyalgia compared to normal population data using SF-36, Scandinavian journal of rheumatology, vol.29, issue.1, pp.20-28, 2000.

K. D. Hay, R. P. Morton, and C. R. Wall, Quality of life and nutritional studies in Sjogren's syndrome patients with xerostomia. The New Zealand dental journal, vol.97, pp.128-159, 2001.

J. Rostron, S. Rogers, L. Longman, S. Kancy, and E. A. Field, Health-related quality of life in patients with Primary Sjögren's Syndrome and Xerostomia: a comparative study, Gerodontology, vol.19, issue.1, pp.53-62, 2002.